Publishing research using ab150439? Please let us know so that we can cite the reference in this datasheet.

ab150439 has been referenced in 3 publications.

  • Lu J  et al. Eukaryotic translation initiation factor 5A2 is highly expressed in prostate cancer and predicts poor prognosis. Exp Ther Med 17:3741-3747 (2019). PubMed: 30988760
  • Xue F  et al. MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2. Oncol Lett 15:813-820 (2018). PubMed: 29399149
  • Yao M  et al. N1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2. Exp Ther Med 14:2101-2107 (2017). PubMed: 28962130

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up